ATE40116T1 - 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva. - Google Patents

1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.

Info

Publication number
ATE40116T1
ATE40116T1 AT83902866T AT83902866T ATE40116T1 AT E40116 T1 ATE40116 T1 AT E40116T1 AT 83902866 T AT83902866 T AT 83902866T AT 83902866 T AT83902866 T AT 83902866T AT E40116 T1 ATE40116 T1 AT E40116T1
Authority
AT
Austria
Prior art keywords
acyl
pyridylmethylguanidine
antihypertensives
guanidine
pyridylalkyl
Prior art date
Application number
AT83902866T
Other languages
English (en)
Inventor
William Lyon Studt
Harry Karl Zimmerman
Original Assignee
Rorer Int Overseas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Int Overseas filed Critical Rorer Int Overseas
Application granted granted Critical
Publication of ATE40116T1 publication Critical patent/ATE40116T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT83902866T 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva. ATE40116T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/410,959 US4496573A (en) 1982-08-24 1982-08-24 1-Pyridylmethyl-3-acyl guanidines
PCT/US1983/001287 WO1984000963A1 (en) 1982-08-24 1983-08-23 1-acyl-3-pyridylguanidines and their use as antihypertensive agents
EP83902866A EP0116628B1 (de) 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva

Publications (1)

Publication Number Publication Date
ATE40116T1 true ATE40116T1 (de) 1989-02-15

Family

ID=23626973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83902866T ATE40116T1 (de) 1982-08-24 1983-08-23 1-acyl-3-pyridylmethylguanidine und deren verwendung als antihypertensiva.

Country Status (7)

Country Link
US (1) US4496573A (de)
EP (1) EP0116628B1 (de)
JP (1) JPS59501715A (de)
AT (1) ATE40116T1 (de)
AU (1) AU1946983A (de)
DE (1) DE3378979D1 (de)
WO (1) WO1984000963A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
BRPI0411900B8 (pt) * 2003-06-26 2021-05-25 Biotron Ltd compostos e composições farmacêuticas compreendendo os mesmos
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods
US8399443B2 (en) 2009-04-22 2013-03-19 Mercator Medsystems, Inc. Treatment of hypertension by renal vascular delivery of guanethidine
EP2768514B8 (de) * 2011-10-19 2019-06-19 Mercator Medsystems, Inc. Lokalisierte modulation von gewebe und zellen zur verbesserung der therapeutischen wirkung einschliesslich nierendenervierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914306A (en) * 1972-09-22 1975-10-21 Rorer Inc William H Guanidines
GB1461806A (en) * 1974-03-05 1977-01-19 Wyeth John & Brother Ltd Pyridine derivatives
DE2728423A1 (de) * 1977-06-24 1979-01-04 Grote & Hartmann Federkabelschuh
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
US4246406A (en) * 1979-03-27 1981-01-20 Merck & Co., Inc. Heterocyclic substituted pyrazinoylguanidines

Also Published As

Publication number Publication date
EP0116628A4 (de) 1985-02-18
DE3378979D1 (en) 1989-02-23
EP0116628B1 (de) 1989-01-18
AU1946983A (en) 1984-03-29
JPS59501715A (ja) 1984-10-11
US4496573A (en) 1985-01-29
EP0116628A1 (de) 1984-08-29
WO1984000963A1 (en) 1984-03-15

Similar Documents

Publication Publication Date Title
FI963070A0 (fi) Klooripyrimidiinivälituotteita
ATE234092T1 (de) 2-alkylpyrrolidine
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ATE27457T1 (de) 1,2,4-triazine und pyrazin-derivate.
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
ES2152483T3 (es) Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b.
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
FI916129A0 (fi) Substituerade imidazoler.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
DK283881A (da) Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
FR2491334B1 (de)
NO890046L (no) Disubstituerte pyridiner.
BG101126A (en) The use of muramylpeptide compounds
DE58906338D1 (de) Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln.
ATE39694T1 (de) (pyrrol-1-yl)-phenyl-dihydropyridazinone, ihre herstellung und verwendung.
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
IT8420213A0 (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
IT1237088B (it) N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties